Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://nikolasmefk513744.myparisblog.com/41100133/tirzepatide-a-new-frontier-in-diabetes-treatment